Translational Session

Combating Kidney Diseases: Joint ASN-JSN Session

November 07, 2019 | 02:00 PM - 04:00 PM

Location: Salon C, Walter E. Washington Convention Center

Session Description

Cutting-edge science that crosses the spectrum of AKI and CKD is the center of this session. The common theme is novel pathophysiologic mechanisms in kidney diseases. The goal is to begin to define new targets for treatment of kidney diseases. The session starts off with a discussion of the role of erythropoietin-producing cells in kidney fibrosis and follows up with a presentation on the role of oxidant stress in AKI. Detailed information on oxygen metabolism in AKI and CKD is reviewed. The session ends with a presentation on neuro-immune regulation in kidney diseases.

ASN thanks the Japanese Society of Nephrology for assistance with this session.

Learning Objective(s)

  • Describe novel pathophysiologic mechanisms in AKI and CKD
  • Identify new therapeutic treatment targets in kidney diseases
  • Define the role of oxygen metabolism and oxidant stress in kidney diseases
  • Explain the role of neuro-immune regulation in kidney diseases

Learning Pathway(s)

  • Other

Moderators

  • Naoki Kashihara, MD, PhD
  • Mark D. Okusa, MD, FASN

Presentations

  • Erythropoietin-Producing Cells in Kidney Fibrosis
    02:00 PM - 02:30 PM
    Motoko Yanagita, MD, PhD 
  • Oxidative Stress in AKI
    02:30 PM - 03:00 PM
    Subhashini Bolisetty, PhD
  • Oxygen Metabolism in AKI and CKD
    03:00 PM - 03:30 PM
    Masaomi Nangaku, MD, PhD 
  • Neuro-Immune Regulation in Kidney Diseases
    03:30 PM - 04:00 PM
    Shinji Tanaka, MD, PhD